We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Rosacea induced by selexipag in a patient with pulmonary arterial hypertension.
- Authors
Dominguez‐Santas, Miguel; Diaz‐Guimaraens, Borja; Burgos‐Blasco, Patricia; Ortega‐Quijano, Daniel; Suarez‐Valle, Ana; Saceda‐Corralo, David
- Abstract
Rosacea is a common skin condition with multiple pathophysiologic pathways and triggers involved (alcohol, heat, neurovascular dysregulation, aberrant innate immunity, skin barrier dysfunction, and I Demodex folliculorum i infestation).1 This manuscript reports what we believe to be the first case of rosacea triggered by selexipag, a recently approved oral selective nonprostanoid prostacyclin receptor (IP receptor) agonist. Dermatological examination 16 weeks after initiation of selexipag showed erythematous papules and pustules over a background of persistent facial erythema, distributed mainly on the forehead, malar area, and chin (Figure 1). GLO:ETZ/01nov20:dth13947-fig-0001.jpg PHOTO (COLOR): 1 Erythematous papules and pustules over a background of persistent facial erythema, distributed mainly on the forehead, malar area, and chin gl She was treated with oral doxycycline (100 mg daily) for 3 months.
- Subjects
ROSACEA; PULMONARY hypertension; CYCLIC adenylic acid; G protein coupled receptors; OINTMENTS
- Publication
Dermatologic Therapy, 2020, Vol 33, Issue 6, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.13947